Evidence map›Paper›PMID 21246361›Full record

ReviewRheumatology international2011

Relapsing polychondritis: a description of a case and review article.

Amr Edrees

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Lung Cancer Complicated by Relapsing Polychondritis.Internal medicine (Tokyo, Japan) · 2023
    Article
  2. Article
  3. Red-eared zebra diagnosis: Case of relapsing polychondritis.Canadian family physician Medecin de famille canadien · 2018
    Article
  4. Article
  5. Review
  6. Article
  7. Febrile conditions in rheumatology.Clinical rheumatology · 2012
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Amr EdreesUniversity of Missouri-Kansas City, Kansas City, MO, USA. edreesa@umkc.edu
University of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsing polychondritis (RPC) is a rare autoimmune disease in which the cartilaginous tissues are the target for inflammation and destruction, the associated immune reaction causes inflammation in non-cartilaginous tissues like kidney and blood vessels. This article provides a description of a case of RPC and a review article about the disease.

Indexed as

Anti-Inflammatory AgentsAutoimmunityDrug Therapy, CombinationEarFemaleHumansImmunosuppressive AgentsMethotrexateMiddle AgedPolychondritis, RelapsingPrednisoloneTreatment OutcomeAnti-Inflammatory AgentsImmunosuppressive AgentsMethotrexatePrednisolone

Identifiers

PMID21246361
OpenAlexW1965693618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.